HEALTHMay 28 · 15:03 UTCNY POSTFox News

GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study

A new study found that GLP-1 weight-loss medications may slow the spread of several obesity-related cancers, including breast, prostate, lung, colorectal, and liver cancers.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GLP-1 drugstopicbreast cancertopicprostate cancertopiclung cancertopiccolorectal cancertopicliver cancertopicobesity-related cancerstopicweight-loss medicationstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 26 · 11:00 UTC
Ozempic-style drugs linked to major slowdown in cancer spread, new study finds
HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHMay 21 · 21:00 UTC
Weight loss jabs may help stop cancer from spreading, study reveals
HEALTHMay 21 · 13:02 UTC
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
HEALTHMay 14 · 11:00 UTC
Experimental obesity drug outperforms traditional weight-loss treatments in early research
HEALTHMay 27 · 00:00 UTC
Could a pill prevent the world’s deadliest cancer?